Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
993 studies found for:    Open Studies | "Prostatic Neoplasms"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Prostatic Neoplasms" (993 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Stereotactic Body Radiotherapy for Stage I-III Prostate Cancer
Conditions: Prostate Cancer;   Prostatic Cancer;   Prostate Neoplasms;   Prostatic Neoplasms;   Cancer of the Prostate
Intervention: Radiation: CyberKnife Stereotactic Radiosurgery
2 Recruiting A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer
Conditions: Prostatic Neoplasms;   Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Interventions: Drug: Abiraterone Acetate;   Drug: Prednisone;   Drug: JNJ-56021927
3 Recruiting Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer
Conditions: Prostate Cancer;   Metastatic Prostate Cancer;   Androgen-independent Prostate Cancer;   Recurrent Prostate Cancer
Interventions: Drug: onapristone;   Drug: abiraterone
4 Recruiting Irreversible Electroporation(IRE) For Unresectable Prostatic Neoplasms
Condition: Prostatic Neoplasms
Interventions: Procedure: Irreversible electroporation (IRE);   Device: NanoKnife
5 Recruiting Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy
Conditions: Prostatic Neoplasms;   Prostate Cancer
Intervention:
6 Recruiting CEUS Targeted Biopsies Compared to mpMRI Targeted and Systematic Biopsies for the Detection of Prostate Cancer
Conditions: Prostate Cancer;   Prostatic Neoplasms
Interventions: Other: CEUS and targeted biopsies;   Other: MRI and targeted biopsies
7 Recruiting Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Men With Stage D0 Prostate Cancer
Conditions: Prostatic Neoplasms;   Prostate Cancer
Interventions: Biological: Autologus elutriated monocyte placebo vaccine;   Biological: ME TARP vaccine
8 Recruiting Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)
Conditions: Prostate Cancer;   Castration-resistant Prostate Cancer;   Metastatic Prostate Cancer
Intervention:
9 Recruiting A Canadian Observational Study in Metastatic Cancer of the Prostate: A Study of ZYTIGA Use in the Community Urology Setting
Condition: Prostatic Neoplasms
Intervention: Other: Abiraterone Acetate (ZYTIGA): Prostate Cancer Registry
10 Recruiting A Biomarker Study of Standard-of-care Radium-223 Chloride for Metastatic Castration-resistant Prostate Cancer
Conditions: Prostate Cancer;   Castration-resistant Prostate Cancer;   Castration-resistant Prostate Cancer Metastatic to Bone
Interventions: Procedure: Blood Tests;   Procedure: CT scan and bone scan;   Procedure: FACBC PET/MRI in a subset of participants
11 Recruiting Docetaxel Plus Lycopene in Castration Resistant, Chemotherapy-Naïve Prostate Cancer Patients
Conditions: Adenocarcinoma of the Prostate;   Recurrent Prostate Cancer;   Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer
Interventions: Drug: Docetaxel;   Dietary Supplement: Lycopene
12 Recruiting Tangerine or Red Tomato Juice in Treating Patients With Prostate Cancer Undergoing Surgery
Conditions: Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Dietary Supplement: dietary intervention (tangerine tomato juice);   Dietary Supplement: dietary intervention (red tomato juice);   Other: questionnaire administration;   Other: Correlative studies
13 Recruiting A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer
Conditions: Prostate Cancer;   Castration-resistant Prostate Cancer;   Metastatic Prostate Cancer
Intervention:
14 Recruiting Cabozantinib in Treating Men With Castration-Resistant Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Castration-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage III Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: cabozantinib-s-malate;   Other: laboratory biomarker analysis
15 Recruiting A Pilot Study to Enhance F18 FDG-PET Imaging of Prostate Cancers With the Metabolic Inhibitor Ranolazine
Conditions: Adenocarcinoma of the Prostate;   Bone Metastases;   Soft Tissue Metastases;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer;   Stage IV Prostate Cancer
Intervention: Drug: Ranolazine
16 Recruiting Safety & Immunogenicity of JNJ-64041809, a Live Attenuated Double-deleted Listeria Immunotherapy, in Participants With Metastatic Castration-resistant Prostate Cancer
Condition: Prostatic Neoplasms, Castration-Resistant
Interventions: Biological: JNJ-64041809 (Cohort 1A and 1B);   Biological: JNJ-64041809 (Cohort 2A and 2B)
17 Recruiting A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer
Condition: Prostatic Neoplasms, Castration-Resistant
Interventions: Drug: JNJ 56021927;   Drug: Drug Cocktail;   Drug: Pioglitazone;   Drug: Rosuvastatin
18 Recruiting An Efficacy and Safety Study of JNJ-56021927 (ARN-509) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS
Condition: Prostatic Neoplasms
Interventions: Drug: JNJ-56021927;   Drug: Bicalutamide;   Drug: Bicalutamide Placebo;   Drug: JNJ-56021927 Placebo;   Drug: GnRH (agonist);   Radiation: 74-80 Grays (units of radiation)
19 Not yet recruiting Focal Therapy for Prostate Cancer
Conditions: Prostatic Neoplasms;   Prostate Cancer
Intervention: Radiation: Brachytherapy
20 Recruiting 18F-DCFBC PET/CT in Prostate Cancer
Conditions: Prostatic Neoplasms;   Prostate Cancer
Intervention: Drug: 18F DCFBC

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years